Clinical. The ABCs of cognitive-behavioral therapy for schizophrenia
Clinical. The ABCs of cognitive-behavioral therapy for schizophrenia
Cognitive-behavioral therapy (CBT) in schizophrenia was originally developed to provide additional treatment for residual symptoms, drawing on the principles and intervention strategies previously developed for anxiety and depression. In the 1950s, Aaron Beck1 had already treated a psychotic patient with a cognitive approach, but thereafter the research in this specific area lay dormant for decades. Only after cognitive therapy had been firmly established for depression and anxiety, in the 1990s, did the research into psychological treatments for psychotic conditions gather force—again, with Beck in the forefront.
Pharmacologic therapy can leave as many as 60% of psychotic patients with persistent positive and negative symptoms, even when the patients are compliant with their medication instructions.2 Furthermore, medication compliance remains a major problem despite the introduction of modern atypical antipsychotics. Studies have shown treatment discontinuation in an estimated 74% of patients in both outpatient and inpatient settings.3
The evidence for the efficacy of CBT in treating patients with persistent symptoms of schizophrenia has progressed from case studies, case series, and uncontrolled trials to methodologically rigorous, randomized, controlled trials that include patients from both the acute4 and the chronic end of the schizophrenia spectrum.5-7 Subsequent meta-analysis8 and systematic reviews have further strengthened the evidence base.
CBT is now recognized as an effective intervention for schizophrenia in clinical guidelines developed in the United States9 and in Europe.10 In spite of the evidence base and absence of side effects, however, the general availability of this treatment approach within community settings is still low.11 This article will examine the procedure of CBT for psychosis, the evidence for its use, and the implications for practicing psychiatrists.
schizophrenia
49-50
Hansen, Lars
c07afee9-a9d5-4d89-9703-2a603a23b8fe
Kingdon, David
14cdc422-10b4-4b2d-88ec-24fde5f4329b
Turkington, Douglas
3e0aca69-c932-4fb6-9145-6e19c7310700
20 June 2006
Hansen, Lars
c07afee9-a9d5-4d89-9703-2a603a23b8fe
Kingdon, David
14cdc422-10b4-4b2d-88ec-24fde5f4329b
Turkington, Douglas
3e0aca69-c932-4fb6-9145-6e19c7310700
Hansen, Lars, Kingdon, David and Turkington, Douglas
(2006)
Clinical. The ABCs of cognitive-behavioral therapy for schizophrenia.
Psychiatric Times, 23 (7), .
Abstract
Cognitive-behavioral therapy (CBT) in schizophrenia was originally developed to provide additional treatment for residual symptoms, drawing on the principles and intervention strategies previously developed for anxiety and depression. In the 1950s, Aaron Beck1 had already treated a psychotic patient with a cognitive approach, but thereafter the research in this specific area lay dormant for decades. Only after cognitive therapy had been firmly established for depression and anxiety, in the 1990s, did the research into psychological treatments for psychotic conditions gather force—again, with Beck in the forefront.
Pharmacologic therapy can leave as many as 60% of psychotic patients with persistent positive and negative symptoms, even when the patients are compliant with their medication instructions.2 Furthermore, medication compliance remains a major problem despite the introduction of modern atypical antipsychotics. Studies have shown treatment discontinuation in an estimated 74% of patients in both outpatient and inpatient settings.3
The evidence for the efficacy of CBT in treating patients with persistent symptoms of schizophrenia has progressed from case studies, case series, and uncontrolled trials to methodologically rigorous, randomized, controlled trials that include patients from both the acute4 and the chronic end of the schizophrenia spectrum.5-7 Subsequent meta-analysis8 and systematic reviews have further strengthened the evidence base.
CBT is now recognized as an effective intervention for schizophrenia in clinical guidelines developed in the United States9 and in Europe.10 In spite of the evidence base and absence of side effects, however, the general availability of this treatment approach within community settings is still low.11 This article will examine the procedure of CBT for psychosis, the evidence for its use, and the implications for practicing psychiatrists.
This record has no associated files available for download.
More information
Published date: 20 June 2006
Keywords:
schizophrenia
Identifiers
Local EPrints ID: 62399
URI: http://eprints.soton.ac.uk/id/eprint/62399
ISSN: 0893-2905
PURE UUID: 2bb07f45-7700-42d1-bba3-ea125b80c65b
Catalogue record
Date deposited: 12 Sep 2008
Last modified: 08 Jan 2022 04:03
Export record
Contributors
Author:
Lars Hansen
Author:
David Kingdon
Author:
Douglas Turkington
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics